{'fraction_non_alphanumeric': 0.03598484848484849, 'fraction_numerical': 0.01893939393939394, 'mean_word_length': 5.451219512195122, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Prevention of pulmonary thromboembolism by percutaneous implantation of REPTELA vena cava-filter].

Experience in clinical application of the new antiembolic REPTELA cava-filter is generalized. The immediate (750 patients) and late-term results (400 patients) of implantation of the filter are discussed. Thromboembolism of the pulmonary artery was encountered in the postimplantation period in 1.2% of patients with 0.2% lethality. Technical faults of implantation were the causes of antiembolic inefficacy of the cava-filter.